Chiron Real Estate (XRN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Initiated a strategic repositioning to focus on senior housing operating properties, now representing over 25% of asset value, with a goal to become a leading capital provider for essential healthcare operators.
Announced agreements to acquire three Class-A/luxury senior housing communities in the Washington, D.C. metro area for $425 million, targeting high-quality, supply-constrained markets and expected to deliver double-digit unlevered IRRs.
Secured a $100 million strategic/convertible preferred equity investment from Maewyn Capital Partners, with board representation to enhance capital allocation discipline.
Reduced annual dividend by approximately 36% to $1.92 per share or $0.16 per month, freeing $15 million annually to support growth and capital retention.
No property acquisitions or dispositions completed in Q1 2026; investment activity focused on a new joint venture for an active adult community.
Financial highlights
Nareit defined FFO per share and unit was $0.97 for the quarter; Core FFO was $1.11 per share and unit, unchanged year-over-year.
Net (loss) income attributable to common stockholders was $(0.06) per share, compared to $0.16 per share in Q1 2025; total revenue for Q1 2026 increased 10% year-over-year to $38.1 million.
Same-store cash NOI increased 3.2% year-over-year.
Net debt to Adjusted EBITDA improved to 6.6x, down 0.4x year-over-year.
FAD for the quarter was $13.3 million, nearly unchanged year-over-year.
Outlook and guidance
Withdrew 2026 earnings guidance due to active portfolio transition and capital redeployment; focus shifted to long-term value creation and capital allocation objectives.
Long-term earnings growth target of 6% expected to be reached by the second half of 2028, with stabilization beginning in 2027-2028.
Latest events from Chiron Real Estate
- Q3 2024 featured resilient occupancy, lower net income, and active acquisitions amid market challenges.XRN
Q3 20248 Jul 2026 - Portfolio shift to higher-return senior housing assets and JV unlocks $200M for reinvestment.XRN
Corporate presentation6 Jul 2026 - Q3 2025 net loss from impairment, but FFO/AFFO and rental revenue grew year-over-year.XRN
Q3 202530 Jun 2026 - AFFO and FFO rose, occupancy remained high, and dividend was cut to support growth and stability.XRN
Q2 202530 Jun 2026 - AFFO guidance reaffirmed as net income rises and portfolio expands despite tenant bankruptcy.XRN
Q1 202530 Jun 2026 - Q2 net loss from property sale, but AFFO, occupancy, and acquisition activity remain strong.XRN
Q2 202430 Jun 2026 - Strong Q4 results and stable AFFO, with acquisitions and JV supporting 2025 growth.XRN
Q4 202430 Jun 2026 - Healthcare REIT registers Series C Preferred and Common Stock for resale by major investors.XRN
Registration filing16 Jun 2026 - Strategic acquisitions and a diversified portfolio drive growth and support a well-covered dividend.XRN
Investor presentation7 May 2026